MARKET

RIGL

RIGL

Rigel Pharms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.410
-0.080
-3.21%
After Hours: 2.410 0 0.00% 16:22 01/29 EST
OPEN
2.510
PREV CLOSE
2.490
HIGH
2.510
LOW
2.390
VOLUME
1.12M
TURNOVER
--
52 WEEK HIGH
3.100
52 WEEK LOW
1.560
MARKET CAP
403.94M
P/E (TTM)
-8.6784
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of RIGL and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

RIGL News

  • What Company Will Eli Lilly Buy Next?
  • MotleyFool.com.6d ago
  • 2 Biotechs Battling Immune Diseases
  • MotleyFool.com.01/19 13:00
  • The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom Disappointment Inflicts Pain On Durect Shares
  • Benzinga.01/17 13:07
  • Here's Why Rigel Pharmaceuticals Is Erupting This Week
  • MotleyFool.com.01/16 17:14

More

Industry

Biotechnology & Medical Research
-0.29%
Pharmaceuticals & Medical Research
+0.09%

Hot Stocks

Name
Price
%Change

About RIGL

Rigel Pharmaceuticals, Inc., is a clinical-stage biotechnology company. The Company is engaged in discovering, developing and providing novel small molecule drugs that improve the lives of patients with immune and hematological disorders, cancer and rare diseases. The Company’s research focuses on signaling pathways that are critical to disease mechanisms. The Company’s product include TAVALISSE is an oral spleen tyrosine kinase (SYK) inhibitor for the treatment of adult patients with chronic immune thrombocytopenia (ITP). Its current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase I study for its interleukin receptor associated kinase (IRAK) program. In addition, it has product candidates in development with partners BerGenBio AS, Daiichi Sankyo and Aclaris Therapeutics.
More

Webull offers Rigel Pharmaceuticals, Inc. (RIGL) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.